Tomoko Haruma

Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy

Junko Haraga, Keiichiro Nakamura, Chiaki Omichi et al. · Molecular and Clinical Oncology · 2016 · 78 citations · Full text

Pre-treatment neutrophil to lymphocyte ratio is a predictor of prognosis in endometrial cancer.

Tomoko Haruma, Keiichiro Nakamura, Takeshi Nishida et al. · PubMed · 2015 · 58 citations

Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability

Tomoko Haruma, Takeshi Nagasaka, Keiichiro Nakamura et al. · PLoS ONE · 2018 · 49 citations · Full text

The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer

Keiichiro Nakamura, Ikuo Joja, Chikako Fukushima et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 44 citations

Primary Tumour, Tumoral Pathology, Gynecological Surgery +10

Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy

Keiichiro Nakamura, Takeshi Nishida, Tomoko Haruma et al. · Molecular and Clinical Oncology · 2015 · 43 citations · Full text